Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-III.

Activities of Daily Living Brain Neoplasms / epidemiology Female Humans Male Middle Aged Psychometrics / methods Quality of Life / psychology Surveys and Questionnaires
Brain tumour Daily functioning IADL Instrumental activities of daily living Questionnaire

Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
May 2021
Historique:
accepted: 14 12 2020
pubmed: 27 1 2021
medline: 18 5 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

Being able to function independently in society is an important aspect of quality of life. This ability goes beyond self-care, requires higher order cognitive functioning, and is typically measured with instrumental activities of daily living (IADL) questionnaires. Cognitive deficits are frequently observed in brain tumour patients, however, IADL is almost never assessed because no valid and reliable IADL measure is available for this patient group. Therefore, this measure is currently being developed. This international multicentre study followed European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group module development guidelines. Three out of four phases are completed: phases (I) generation of items, (II) construction of the item list, and (III) pre-testing. This paper reports the item selection procedures and preliminary psychometric properties of the questionnaire. Brain tumour patients (gliomas and brain metastases), their informal caregivers, and health care professionals (HCPs) were included. Phase I (n = 44 patient-proxy dyads and 26 HCPs) generated 59 relevant and important activities. In phase II, the activities were converted into items. In phase III (n = 85 dyads), the 59 items were pre-tested. Item selection procedures resulted in 32 items. Exploratory factor analysis revealed a preliminary dimensional structure consisting of five scales with acceptable to excellent internal consistency (α = 0.73-0.94) and two single items. For three scales, patients with cognitive impairments had significantly more IADL problems than patients without impairments. A phase IV validation study is needed to confirm the psychometric properties of the EORTC IADL-BN32 questionnaire in a larger international sample.

Identifiants

DOI: 10.1007/s11136-020-02738-5 PMID: 33496902 PMC: PMC8068708
pubmed: 33496902
doi: 10.1007/s11136-020-02738-5
pii: 10.1007/s11136-020-02738-5
pmc: PMC8068708
doi:

Types de publication

Clinical Trial, Phase I Clinical Trial, Phase II Clinical Trial, Phase III Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1491-1502

Subventions

Organisme : European Organisation for Research and Treatment of Cancer
ID : 004/2014

Références

Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist, 9(3), 179–186.
doi: 10.1093/geront/9.3_Part_1.179
Passler, J. S., Kennedy, R. E., Clay, O. J., et al. (2020). The relationship of longitudinal cognitive change to self-reported IADL in a general population. Aging, Neuropsychology, and Cognition, 27(1), 125–139.
doi: 10.1080/13825585.2019.1597008
Koster, N., Knol, D. L., Uitdehaag, B. M., Scheltens, P., & Sikkes, S. A. (2015). The sensitivity to change over time of the Amsterdam IADL Questionnaire((c)). Alzheimers Dement, 11(10), 1231–1240. https://doi.org/10.1016/j.jalz.2014.10.006 .
doi: 10.1016/j.jalz.2014.10.006 pubmed: 25598195
Bosma, I., Vos, M. J., Heimans, J. J., et al. (2007). The course of neurocognitive functioning in high-grade glioma patients1. Neuro-Oncology, 9(1), 53–62.
doi: 10.1215/15228517-2006-012
Oort, Q., Taphoorn, M. J. B., Sikkes, S. A. M., Uitdehaag, B. M. J., Reijneveld, J. C., & Dirven, L. (2019). Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumors. Journal of Neuro-oncology, 143(1), 1–13. https://doi.org/10.1007/s11060-019-03136-9 .
doi: 10.1007/s11060-019-03136-9 pubmed: 30887244 pmcid: 6482128
Sikkes, S. A., de Lange-de Klerk, E. S., Pijnenburg, Y. A., et al. (2012). A new informant-based questionnaire for instrumental activities of daily living in dementia. Alzheimers Dement, 8(6), 536–543. https://doi.org/10.1016/j.jalz.2011.08.006 .
doi: 10.1016/j.jalz.2011.08.006 pubmed: 23102123
Sikkes, S. A., Knol, D. L., Pijnenburg, Y. A., de Lange-de Klerk, E. S., Uitdehaag, B. M., & Scheltens, P. (2013). Validation of the Amsterdam IADL Questionnaire(c), a new tool to measure instrumental activities of daily living in dementia. Neuroepidemiology, 41(1), 35–41. https://doi.org/10.1159/000346277 .
doi: 10.1159/000346277 pubmed: 23712106
Sikkes, S. A., Pijnenburg, Y. A., Knol, D. L., de Lange-de Klerk, E. S., Scheltens, P., & Uitdehaag, B. M. (2013). Assessment of instrumental activities of daily living in dementia: Diagnostic value of the Amsterdam Instrumental Activities of Daily Living Questionnaire. Journal of Geriatric Psychiatry and Neurology, 26(4), 244–250. https://doi.org/10.1177/0891988713509139 .
doi: 10.1177/0891988713509139 pubmed: 24212244
Oort, Q., Dirven, L., Meijer, W., et al. (2017). Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: A pilot study. Journal of Neuro-Oncology, 132(1), 145–153. https://doi.org/10.1007/s11060-016-2352-1 .
doi: 10.1007/s11060-016-2352-1 pubmed: 28150189 pmcid: 5352794
Gehrke, A. K., Baisley, M. C., Sonck, A. L. B., Wronski, S. L., & Feuerstein, M. (2013). Neurocognitive deficits following primary brain tumor treatment: Systematic review of a decade of comparative studies. Journal of Neuro-Oncology, 115(2), 135–142.
doi: 10.1007/s11060-013-1215-2
Hugo, J., & Ganguli, M. (2014). Dementia and cognitive impairment: Epidemiology, diagnosis, and treatment. Clinics in Geriatric Medicine, 30(3), 421–442. https://doi.org/10.1016/j.cger.2014.04.001 .
doi: 10.1016/j.cger.2014.04.001 pubmed: 25037289 pmcid: 4104432
Fayers, P., & Machin, D. (2000). Quality of life. Assessment, analysis and interpretation. Chichester: Wiley.
doi: 10.1002/0470846283
Howorth, P., & Saper, J. (2003). The dimensions of insight in people with dementia. Aging & Mental Health, 7(2), 113–122. https://doi.org/10.1080/1360786031000072286 .
doi: 10.1080/1360786031000072286
Johnson, C., Aaronson, & N., Blazeby, J. M., et al. (2011). EORTC Quality of Life Group: Guidelines for developing questionnaire modules (4th ed.). EORTC Quality of Life Group.
EORTC QOL Item Library. https://qol.eortc.org/item-library/ .
Kulis, D., Bottomley, A., Velikova, G., Greimel, E., & Koller, M. (2017) EORTC Quality of Life Group Translation Procedure.
Kline, P. (2000). The handbook of psychological testing. Psychology Press..
EORTC QLQ-C30 Scoring Manual. EORTC QOL Group. (2001).
IBM Corp. IBM SPSS Statistics for Windows, Version 24.0. (2016).
Schneider, S.L. (2011). The International Standard Classification of Education 2011. in Class and Stratification Analysis, pp. 365–379.
Ediebah, D. E., Reijneveld, J. C., Taphoorn, M. J., et al. (2017). Impact of neurocognitive deficits on patient–proxy agreement regarding health-related quality of life in low-grade glioma patients. Quality of Life Research, 26(4), 869–880. https://doi.org/10.1007/s11136-016-1426-z .
doi: 10.1007/s11136-016-1426-z pubmed: 27744512

Auteurs

Quirien Oort (Q)

Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, PO BOX 7057, 1007 MB, Amsterdam, The Netherlands. q.oort@amsterdamumc.nl.
ORCID: 0000-0001-8130-4054

Linda Dirven (L)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.

Sietske A M Sikkes (SAM)

Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Alzheimer Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Clinical Developmental & Clinical Neuropsychology, Faculty of Behavioural and Movement Sciences (FGB), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Neil Aaronson (N)

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Florien Boele (F)

Leeds Institute of Medical Research, St James's University Hospital, Leeds, LS9 7TF, UK.
Faculty of Medicine and Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, LS2 9JT, UK.

Christine Brannan (C)

East & North Hertfordshire NHS Trust Incorporating Mount Vernon Cancer Centre, Northwood, UK.

Jonas Egeter (J)

Department for Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.

Robin Grant (R)

Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.

Martin Klein (M)

Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Irene Lips (I)

Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.

Yoshitaka Narita (Y)

Department of Neurosurgery and Neuro-Oncology, National Cancer Center, Tokyo, Japan.

Hitomi Sato (H)

Department of Neurosurgery and Neuro-Oncology, National Cancer Center, Tokyo, Japan.
Department of Nursing, Teikyo Heisei University, Tokyo, Japan.

Monika Sztankay (M)

Department for Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.

Günther Stockhammer (G)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Andrea Talacchi (A)

Department of Neurosurgery, Azienda Ospedaliera San Giovanni Addolorata, Rome, Italy.

Bernard M J Uitdehaag (BMJ)

Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, PO BOX 7057, 1007 MB, Amsterdam, The Netherlands.

Jaap C Reijneveld (JC)

Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, PO BOX 7057, 1007 MB, Amsterdam, The Netherlands.
Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.

Martin J B Taphoorn (MJB)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Réadaptation › Activités de la vie quotidienne › Development of an EORTC questionnaire...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs du cerveau › Development of an EORTC questionnaire...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Development of an EORTC questionnaire...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Development of an EORTC questionnaire...
questionsmedicales.fr › Disciplines et activités comportementales › Tests psychologiques › Psychométrie › Development of an EORTC questionnaire...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Development of an EORTC questionnaire...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Development of an EORTC questionnaire...